Craft

Electromed

Stock Price

$22.9

2024-10-29

Market Capitalization

$192.3 M

2024-10-29

Revenue

$64 M

FY, 2025

Electromed Summary

Company Summary

Overview
Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy. The SmartVest System generates HFCWO, also known as High-Frequency Chest Compression, a technique for airway clearance therapy. The garment repeatedly compresses and releases the upper body at frequencies from 5 to 20 cycles per second creating a “mini cough”. Each compression (or oscillation) produces pulsations that thin and loosen secretions from the surfaces of the lung airways, thins mucus stuck in the lungs and propels them toward the mouth where they can be removed by normal coughing or suction.
Type
Public
Status
Active
Founded
1992
HQ
New Prague, MN, US | view all locations
Website
http://smartvest.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Kathleen Skarvan

    Kathleen Skarvan, President, CEO

  • Michelle Wirtz

    Michelle Wirtz, Interim Chief Financial Officer

  • Kristine Owata

    Kristine Owata, VP, Reimbursement & Payer Relations

  • Christopher Holland

    Christopher Holland, Chief Commercial Officer

LocationsView all

1 location detected

  • New Prague, MN HQ

    United States

    500 6th Ave NW

Electromed Financials

Summary Financials

Revenue (Q2, 2026)
$18.9M
Gross profit (Q2, 2026)
$14.8M
Net income (Q2, 2026)
$2.8M
Cash (Q2, 2026)
$13.8M
EBIT (Q2, 2026)
$3.6M

Footer menu